Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Clinical Researchers and Pharmaceutical Regulatory Affairs Pros Benefit from BioPharma Institute's Newly Accredited Training Programs
  • USA - English


News provided by

BioPharma Institute

Mar 24, 2015, 07:00 ET

Share this article

Share toX

Share this article

Share toX

BioPharma Institute offers newly accredited online training to clinical research and regulatory affairs professionals
BioPharma Institute offers newly accredited online training to clinical research and regulatory affairs professionals
Youtube
Youtube

A lack of training and experience in good clinical practice and good documentation requirements has, in some cases, been determined to be the root cause of poor documentation. This has led to FDA 483 warning letters being issued.

Post this

Paramus, New Jersey (PRWEB) March 24, 2015 -- “Excellence in training is a critical factor in the equation to improve the quality professionals working in the clinical research and pharmaceutical industry are able to provide. A lack of training and experience in good clinical practice and good documentation requirements has, in some audits, been determined to be the root cause of poor documentation. This has led to FDA 483 warning letters being issued,” says Christina Carmichael, Managing Director for the BioPharma Institute. “The twenty newly accredited, high quality, web-based eLearning courses are critical to ensure ethical research, high quality documentation, and credible data. In addition, they now provide the added value of including CPD (Continuing Professional Development) points for those required by their employers to complete the training. This is a win-win for everyone.”

The BioPharma Institute is best known for its online training designed for the medical device, clinical research, pharmaceutical regulatory affairs, and drug manufacturing industries. In addition to providing training programs for professionals in the industry, the BioPharma Institute also distributes books and offers access to free abridged courses. Furthermore, corporate training managers have access to real-time reporting and can rest assured knowing that training records are maintained and archived, indefinitely.

“Our continuing professional development courses provide the framework for a systematic and ongoing process of education,” explains Carmichael. “Our in-service training, learning, and support activities are all designed to build on a professional’s initial training/education and ensure continuing competence.”

BioPharma Institute Training Helps Move Medicines to Mainstream
Some of BioPharma Institute’s newly accredited courses focus on good clinical practices, from approval, through design, monitoring, evaluation, audits, and pharmacovigilance. Others teach the intricacies of new drug application to marketing authorizations, with an emphasis on region-specific variations.    

“Workers in healthcare, pharmaceutical regulatory affairs, and clinical research industries are on the front-lines of a constantly shifting landscape,” explains Carmichael. “The goal for educators is to help employees stay current with their knowledge so they can effectively move health-related discoveries out of the lab and into the mainstream where they can help people.”

Clinical Research & Pharma Pros Score Points for Continuing Ed
Upon completion of each of the BioPharma Institute’s accredited training courses, participants receive CPD points. The points are awarded by the Faculty of Pharmaceutical Medicine (FPM) of the Royal Colleges of Physicians of the United Kingdom. CPD points are desired by healthcare providers such as doctors working as investigators and nurses working in clinical research associate or coordinator capacities.

The FPM is a professional membership organization and standard-setting body whose members work in diverse environments including clinical trials, pharmaceutical marketing, and the regulation of medicines.

Making Continuing Professional Ed the Rule, Not the Exception in Healthcare
Carmichael notes that most countries do not have strict legal requirements regarding the continuing education of biotech, healthcare, and pharmaceutical professionals. In those instances, the drive for continuing education must be initiated, provided, and promoted by:

• Medical associations
• Professional organizations
• For-profit healthcare companies
• The pharmaceutical/medical technology industry
• Consumer organizations
• Academic institutions
• Non-governmental organizations
• Ministries of health
• For-profit CPD providers (including the BioPharma Institute)

“Changes come at lightning speed in quickly evolving industries such as healthcare, biotech, and pharma,” says Carmichael. “You can take steps to grow and evolve, or you can stay the same and ultimately become obsolete. The BioPharma Institute’s mission is to provide relevant and current training for these industries, worldwide.”

About The BioPharma Institute
The BioPharma Institute, located in Paramus, New Jersey, offers convenient, efficient, and effective training solutions targeting the continuing professional development needs of those working within the pharma, clinical research, biotech, and healthcare industries. Since its establishment in 2003, the BioPharma Institute has worked to aggregate a comprehensive offering of web-based courses, books, and other training tools. For more information regarding the BioPharma Institute, its course offerings, and other services, you may call (888) 4-BIO-LRN or (201) 301-8370, or use the website contact us form.

Christina Carmichael, BioPharma Institute, http://www.BiopharmaInstitute.com/, (201) 301-8370 Ext: 202, [email protected]

Modal title

BioPharma Institute Introduction PPT
View PDF
BioPharma Institute Introduction PPT
BioPharma Institute Introduction PPT

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.